Carfilzomib in relapsed or refractory multiple myeloma patients with early or late relapse following prior therapy: a subgroup analysis of the randomized phase 3 ASPIRE and ENDEAVOR trials - Mateos, Maria-Victoria; Goldschmidt, Hartmut (Hematological oncology, 2018)
First published: 15 February 2018